China SXT Pharmaceuticals Inc (SXTC)
1.15
+0.17
(+17.50%)
USD |
NASDAQ |
May 07, 16:00
1.27
+0.12
(+10.43%)
After-Hours: 19:08
China SXT Pharmaceuticals Shareholders Equity (Quarterly): 5.076M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.076M |
| September 30, 2023 | 5.076M |
| March 31, 2023 | 14.69M |
| September 30, 2022 | 14.89M |
| September 30, 2022 | 14.89M |
| March 31, 2022 | 16.42M |
| September 30, 2021 | 13.79M |
| September 30, 2021 | 13.79M |
| March 31, 2021 | 15.96M |
| Date | Value |
|---|---|
| September 30, 2020 | 18.52M |
| September 30, 2020 | 18.52M |
| March 31, 2020 | 9.401M |
| September 30, 2019 | 11.41M |
| September 30, 2019 | 11.41M |
| March 31, 2019 | 11.11M |
| September 30, 2018 | 3.960M |
| September 30, 2018 | 3.960M |
| March 31, 2018 | 3.286M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.076M
Minimum
Sep 2023
18.52M
Maximum
Sep 2020
13.13M
Average
14.24M
Median
Shareholders Equity (Quarterly) Benchmarks
| Jin Medical International Ltd | 23.98M |
| Sinovac Biotech Ltd | 8.709B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 796.12M |
| I-MAB | 242.38M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.59M |
| Total Liabilities (Quarterly) | 9.512M |
| Debt to Equity Ratio | 0.5693 |
| Current Ratio | 1.467 |
| Net Debt Paydown Yield | -12.56% |